Current Neuro-Oncology

Volume 11 Number 9
30 September 2009

Home > Publications > Current Neuro-Oncology > Volume 11, Year 2009 > Number 9, 30 September

Blauwblomme T, Varlet P, Goodden JR, Cuny ML, Piana H, Roujeau T, Dirocco F, Grill J, Kieffer V, Boddaert N, Sainte-Rose C, Puget S.
Forniceal glioma in children. Clinical article.
J Neurosurg Pediatr. 2009 Sep;4(3):249-53. doi: 10.3171/2009.4.PEDS08472. PMID: 19772409. Observational study. ˍ

Ranger A, McDonald W, Bauman GS, Del Maestro R.
Effects of surgical excision and radiation on medulloblastoma cell invasiveness.
Can J Neurol Sci. 2009 Sep;36(5):631-7. doi: 10.1017/s0317167100008155. PMID: 19831134. Laboratory investigation. ˍ

Roldán GB, Scott JN, McIntyre JB, Dharmawardene M, de Robles PA, Magliocco AM, Yan ES, Parney IF, Forsyth PA, Cairncross JG, Hamilton MG, Easaw JC.
Population-based study of pseudoprogression after chemoradiotherapy in GBM.
Can J Neurol Sci. 2009 Sep;36(5):617-22. doi: 10.1017/s0317167100008131. PMID: 19831132. Observational study. ˍ

Scheinemann K, Bartels U, Huang A, Hawkins C, Kulkarni AV, Bouffet E, Tabori U.
Survival and functional outcome of childhood spinal cord low-grade gliomas. Clinical article.
J Neurosurg Pediatr. 2009 Sep;4(3):254-61. doi: 10.3171/2009.4.PEDS08411. PMID: 19772410. Observational study. ˍ

Umesh S, Tandon A, Santosh V, Anandh B, Sampath S, Chandramouli BA, Sastry Kolluri VR.
Clinical and immunohistochemical prognostic factors in adult glioblastoma patients.
Clin Neuropathol. 2009 Sep-Oct;28(5):362-72. PMID: 19788052. Observational study. ˍ

McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A.
Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme.
Neurosurgery. 2009 Sep 1;65(3):463-9. doi: 10.1227/01.NEU.0000349763.42238.E9. PMID: 19687690. Observational study. ˍ

Shamsara J, Sharif S, Afsharnezhad S, Lotfi M, Raziee HR, Ghaffarzadegan K, Moradi A, Rahighi S, Behravan J.
Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
Cancer Invest. 2009 Sep 1;27(8):825-9. doi: 10.1080/07357900902783211. PMID: 19544111. Laboratory investigation. ˍ

Beier CP, Schmid C, Gorlia T, Kleinletzenberger C, Beier D, Grauer O, Steinbrecher A, Hirschmann B, Brawanski A, Dietmaier C, Jauch-Worley T, Kölbl O, Pietsch T, Proescholdt M, Rümmele P, Muigg A, Stockhammer G, Hegi M, Bogdahn U, Hau P.
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study.
BMC Cancer. 2009 Sep 2;9:308. doi: 10.1186/1471-2407-9-308. PMID: 19725960. Interventional study. ˍ

Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, LoRusso PM, Von Hoff DD, de Sauvage FJ, Low JA.
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
N Engl J Med. 2009 Sep 2;361(12):1173-8. doi: 10.1056/NEJMoa0902903. PMID: 19726761. Case report. ˍ

Yauch RL, Dijkgraaf GJ, Alicke B, Januario T, Ahn CP, Holcomb T, Pujara K, Stinson J, Callahan CA, Tang T, Bazan JF, Kan Z, Seshagiri S, Hann CL, Gould SE, Low JA, Rudin CM, de Sauvage FJ.
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.
Science. 2009 Sep 2;326(5952):572-4. doi: 10.1126/science.1179386. PMID: 19726788. Laboratory investigation. ˍ

Frosini D, Ceravolo R, Rossi C, Pesaresi I, Cosottini M, Bonuccelli U.
Bilateral thalamic glioma presenting with parkinsonism.
Mov Disord. 2009 Sep 4;24(14):2168-9. doi: 10.1002/mds.22761. PMID: 19735095. Case report. ˍ

Gadji M, Fortin D, Tsanaclis AM, Drouin R.
Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
Cancer Genet Cytogenet. 2009 Sep 6;194(1):12-22. doi: 10.1016/j.cancergencyto.2009.05.004. PMID: 19737649. Observational study. ˍ

Rogne SG, Konglund A, Meling TR, Scheie D, Johannesen TB, Rønning P, Helseth E.
Intracranial tumor surgery in patients >70 years of age: is clinical practice worthwhile or futile?
Acta Neurol Scand. 2009 Sep 8;120(5):288-94. doi: 10.1111/j.1600-0404.2009.01157.x. PMID: 19737154. Observational study. ˍ
Erratum in: Acta Neurol Scand. 2009 Nov 13;120(6):453. ˍ

Hassler MR, Elandt K, Preusser M, Lehrner J, Binder P, Dieckmann K, Rottenfusser A, Marosi C.
Neurocognitive training in patients with high-grade glioma: a pilot study.
J Neurooncol. 2009 Sep 10;97(1):109-15. doi: 10.1007/s11060-009-0006-2. PMID: 19763790. Interventional study. ˍ

*Pallud J, Duffau H, Razak RA, Barbarino-Monnier P, Capelle L, Fontaine D, Frenay M, Guillet-May F, Mandonnet E, Taillandier L.
Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group.
J Neurol. 2009 Sep 10;256(12):2014-20. doi: 10.1007/s00415-009-5232-1. PMID: 19763385. Observational study. ˍ

Hayashi Y, Nakada M, Tanaka S, Uchiyama N, Hayashi Y, Kita D, Hamada J.
Implication of 5-aminolevulinic acid fluorescence of the ventricular wall for postoperative communicating hydrocephalus associated with cerebrospinal fluid dissemination in patients with glioblastoma multiforme: a report of 7 cases.
J Neurosurg. 2009 Sep 11;112(5):1015-9. doi: 10.3171/2009.8.JNS09516. PMID: 19747042. Case report. ˍ

Prayson NF, Angelov L, Prayson RA.
Microscopic thrombi in glioblastoma multiforme do not predict the development of deep venous thrombosis.
Ann Diagn Pathol. 2009 Sep 12;13(5):291-6. doi: 10.1016/j.anndiagpath.2009.05.002. PMID: 19751904. Observational study. ˍ

*Sonoda Y, Kumabe T, Nakamura T, Saito R, Kanamori M, Yamashita Y, Suzuki H, Tominaga T.
Analysis of IDH1 and IDH2 mutations in Japanese glioma patients.
Cancer Sci. 2009 Sep 14;100(10):1996-8. doi: 10.1111/j.1349-7006.2009.01270.x. PMID: 19765000. Laboratory investigation. ˍ

Casartelli G, Dorcaratto A, Ravetti JL, Sola S, Vitali A, Merlo DF, Frosina G.
Survival of high grade glioma patients depends on their age at diagnosis.
Cancer Biol Ther. 2009 Sep 15;8(18):1719-21. doi: 10.4161/cbt.8.18.9209. PMID: 19633420. Observational study. ˍ

Nobusawa S, Watanabe T, Kleihues P, Ohgaki H.
IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
Clin Cancer Res. 2009 Sep 15;15(19):6002-7. doi: 10.1158/1078-0432.CCR-09-0715. PMID: 19755387. Observational study. ˍ

Leal T, Robins HI.
Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report.
Cancer Chemother Pharmacol. 2009 Sep 16;65(2):399-401. doi: 10.1007/s00280-009-1118-2. PMID: 19756604. Case report. ˍ

*Halkett GK, Lobb EA, Oldham L, Nowak AK.
The information and support needs of patients diagnosed with High Grade Glioma.
Patient Educ Couns. 2009 Sep 16;79(1):112-9. doi: 10.1016/j.pec.2009.08.013. PMID: 19762197. Observational study. ˍ

Hasegawa H, Pal D, Ramirez R, Ismail A, Marks P.
Glioblastoma multiforme fades on CT imaging after dexamethasone therapy.
J Clin Neurosci. 2009 Sep 17;16(12):1707-8. doi: 10.1016/j.jocn.2009.02.024. PMID: 19766006. Case report. ˍ

Rosenfeld A, Kletzel M, Duerst R, Jacobsohn D, Haut P, Weinstein J, Rademaker A, Schaefer C, Evans L, Fouts M, Goldman S.
A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors.
J Neurooncol. 2009 Sep 21;97(2):247-55. doi: 10.1007/s11060-009-0009-z. PMID: 19768658. Interventional study. ˍ

Blatt J, Deal AM, Mesibov G.
Autism in children and adolescents with cancer.
Pediatr Blood Cancer. 2009 Sep 22;54(1):144-7. doi: 10.1002/pbc.22303. PMID: 19774639. Observational study. ˍ

Wang M, Cairncross G, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperriere N, Mehta M, Curran W; Radiation Therapy Oncology Group (RTOG); North Central Cancer Treatment Group (NCCTG); Southwest Oncology Group (SWOG); National Cancer Institute of Canada Clinical Trials Group (NCIC CTG); Eastern Cooperative Oncology Group (ECOG).
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.
Int J Radiat Oncol Biol Phys. 2009 Sep 23;77(3):662-9. doi: 10.1016/j.ijrobp.2009.06.004. PMID: 19783377. Interventional study. ˍ

Weber DC, Casanova N, Zilli T, Buchegger F, Rouzaud M, Nouet P, Vees H, Ratib O, Dipasquale G, Miralbell R.
Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study.
Radiother Oncol. 2009 Sep 24;93(3):586-92. doi: 10.1016/j.radonc.2009.08.043. PMID: 19782417. Interventional study. ˍ

Pérez-Gómez JL, Rodríguez-Alvarez CA, Marhx-Bracho A, Rueda-Franco F.
Stereotactic biopsy for brainstem tumors in pediatric patients.
Childs Nerv Syst. 2009 Sep 26;26(1):29-34. doi: 10.1007/s00381-009-1000-x. PMID: 19784659. Observational study. ˍ

Kang HC, Kim IH, Eom KY, Kim JH, Jung HW.
The role of radiotherapy in the treatment of newly diagnosed supratentorial low-grade oligodendrogliomas: comparative analysis with immediate radiotherapy versus surgery alone.
Cancer Res Treat. 2009 Sep 28;41(3):132-7. doi: 10.4143/crt.2009.41.3.132. PMID: 19809562. Observational study. ˍ

Taylor AJ, Frobisher C, Ellison DW, Reulen RC, Winter DL, Taylor RE, Stiller CA, Lancashire ER, Tudor EC, Baggott C, May S, Hawkins MM.
Survival after second primary neoplasms of the brain or spinal cord in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study.
J Clin Oncol. 2009 Sep 28;27(34):5781-7. doi: 10.1200/JCO.2009.22.4386. PMID: 19786666. Observational study. ˍ

*Ghulam Muhammad AK, Candolfi M, King GD, Yagiz K, Foulad D, Mineharu Y, Kroeger KM, Treuer KA, Nichols WS, Sanderson NS, Yang J, Khayznikov M, Van Rooijen N, Lowenstein PR, Castro MG.
Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression.
Clin Cancer Res. 2009 Sep 29;15(19):6113-27. doi: 10.1158/1078-0432.CCR-09-1087. PMID: 19789315. Laboratory investigation. ˍ

Razis E, Selviaridis P, Labropoulos S, Norris JL, Zhu MJ, Song DD, Kalebic T, Torrens M, Kalogera-Fountzila A, Karkavelas G, Karanastasi S, Fletcher JA, Fountzilas G.
Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Clin Cancer Res. 2009 Sep 29;15(19):6258-66. doi: 10.1158/1078-0432.CCR-08-1867. PMID: 19789313. Interventional study. ˍ